NEPH Nephros
- 2.180
- -0.020-0.91%
- 2.180
- 0.0000.00%
Nephros News
GEE Group And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed lower by over 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders i
Nephros(NEPH.US) Director Buys US$11,176.1 in Common Stock
$Nephros(NEPH.US)$ Director Amron Arthur H purchased 5,000 shares of common stock on May 28, 30, 2024 at an average price of $2.2352 for a total value of $11,176.1.Source: Announcement What is stateme
Insider Buying: President and CEO Banks Robert R. Jr. Acquires 50,000 Shares of Nephros Inc (NEPH)
Nephros(NEPH.US) Officer Buys US$112.05K in Common Stock
$Nephros(NEPH.US)$ Officer Banks Robert R. Jr. purchased 50,000 shares of common stock on May 16, 2024 at an average price of $2.241 for a total value of $112.05K.Source: Announcement What is statemen
Express News | Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target
Earnings Update: Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Are Trimming Their Forecasts
Nephros: Buy Rating Affirmed Amid Solid Performance and Growth Prospects
Express News | Nephros Files For Mixed Shelf Of Up To $50M
Express News | Nephros Inc Files for Mixed Shelf of up to $50 Mln - SEC Filing
Nephros Q1 2024 GAAP EPS $(0.02) Beats $(0.04) Estimate, Sales $3.522M Miss $3.734M Estimate
Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 33.33 percent increase over losses of $(0.03) per sha
Nephros | 10-Q: Quarterly report
Nephros Inc to Present Corporate Strategies at Showcase
Nephros to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Nephros(NEPH.US) Director Buys US$17,129.7 in Common Stocks
$Nephros(NEPH.US)$ Director Amron Arthur H purchased 7,000 shares of Common Stocks on Mar 12, 2024 at an average price of $2.4471 for a total value of $17,129.7.Source: Announcement What is statement
Nephros Director Arthur Amron Buys $17.1k in Company Stock
US$4.75 - That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results
As you might know, Nephros, Inc. (NASDAQ:NEPH) last week released its latest full-year, and things did not turn out so great for shareholders. Revenues missed expectations somewhat, coming in at
Nephros Poised for Growth: A Buy Recommendation Amid Expansion and Optimized Operations
Nephros Raised to Speculative Buy From Hold by Benchmark
Nephros Raised to Speculative Buy From Hold by Benchmark
Nephros Price Target Announced at $5.00/Share by Benchmark
Nephros Price Target Announced at $5.00/Share by Benchmark
Benchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target
Benchmark analyst Robert Wasserman upgrades Nephros from Hold to Speculative Buy and announces $5 price target.
Analysis
Price Target
No Data
